Pten-mediated Gsk3β Modulates the Naïve Pluripotency Maintenance in Embryonic Stem Cells

Wuming Wang,Gang Lu,Xianwei Su,Chengcheng Tang,Hongjian Li,Zhiqiang Xiong,Chi-Kwan Leung,Man-Sze Wong,Hongbin Liu,Jin-Long Ma,Hoi-Hung Cheung,Hsiang-Fu Kung,Zi-Jiang Chen,Wai-Yee Chan
DOI: https://doi.org/10.1038/s41419-020-2271-0
2020-01-01
Cell Death and Disease
Abstract:Mouse embryonic stem cells (ESCs) are isolated from the inner cell mass of blastocysts, and they exist in different states of pluripotency—naïve and primed states. Pten is a well-known tumor suppressor. Here, we generated Pten −/− mouse ESCs with the CRISPR-Cas9 system and verified that Pten −/− ESCs maintained naïve pluripotency by blocking Gsk3β activity. Serum/LIF and 2i (MAPK and GSK3 inhibitors) conditions are commonly used for ESC maintenance. We show that the Pten-inhibitor SF1670 contributed to sustaining mouse ESCs and that Pten activation by the S380A, T382A, and T383A mutations (Pten-A3) suppressed the pluripotency of ESCs. The in vivo teratoma formation ability of SF1670-treated ESCs increased, while the Pten-A3 mutations suppressed teratoma formation. Furthermore, the embryoid bodies derived from Pten -deficient ESCs or SF1670-treated wild-type ESCs showed greater expression of ectoderm and pluripotency markers. These results suggest that Pten-mediated Gsk3β modulates the naïve pluripotency of ESCs and that Pten ablation regulates the lineage-specific differentiation.
What problem does this paper attempt to address?